Advancing outcomes in solid tumor diagnostics
Labcorp Oncology offers comprehensive genomic profiling (CGP) for tissue and liquid biopsy testing to guide more personalized patient care
Our solid tumor offerings
OmniSeq® INSIGHT
OmniSeq® INSIGHT delivers a comprehensive, easy-to-interpret report with clinically actionable insights to help guide targeted therapies and clinical trial options for your patients.
Liquid biopsy portfolio
Our liquid biopsy portfolio enables comprehensive genomic profiling (CGP) from a simple blood draw, as well as detection of molecular residual disease (MRD) and surveillance.
Explore our liquid biopsy solutions
Genomic profiling
Labcorp Plasma Focus
Labcorp Plasma Complete
MRD solution
Labcorp Plasma Detect
elio™ kitted solutions: Your lab, our tests
FDA-authorized tissue and liquid biopsy kitted assays enable you to bring comprehensive genomic profiling (CGP) in-house with just a simple verification step, providing faster results, full control of sample chain of custody and complete data ownership.